Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate

Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate

ABSTRACT Glioblastoma (GBM) is the deadliest type of brain tumor, and glioma stem cells (GSCs) contribute to tumor recurrence and therapeutic resistance. Thus, an oncolytic virus targeting GSCs may be useful for improving GBM treatment. Because Zika virus (ZIKV) has an oncolytic tropism for infectin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qi Chen, Jin Wu, Qing Ye, Feng Ma, Qian Zhu, Yan Wu, Chao Shan, Xuping Xie, Dapei Li, Xiaoyan Zhan, Chunfeng Li, Xiao-Feng Li, Xiaoling Qin, Tongyan Zhao, Haitao Wu, Pei-Yong Shi, Jianghong Man, Cheng-Feng Qin
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
Zika virus
anticancer therapy
glioblastoma
vaccine
Microbiology
QR1-502
Acceso en línea:https://doaj.org/article/07ea5ab958ca49449dd9b7a5bae0a153
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares